FIELD: pharmaceutics.
SUBSTANCE: present invention relates to a pharmaceutical composition for the treatment and/or prevention of malignant tumor expressing MCEMP1 on a cell surface, which contains, as an active ingredient, effective amount of an antibody having immune reactivity with polypeptide containing a part of extracellular area of MCEMP1 protein, where polypeptide is polypeptide consisting of 7 or more subsequent amino acids of amino acid sequence represented in SEQ ID NO: 10. The present invention also relates to a method for the treatment and/or prevention of malignant tumors expressing MCEMP1 on the cell surface, which includes injecting a patient by parenteral injection effective amount of the antibody having immune reactivity with polypeptide containing the part of extracellular area of MCEMP1 protein, where polypeptide is polypeptide consisting of 7 or more subsequent amino acids of amino acid sequence represented in SEQ ID NO: 10.
EFFECT: use of antibodies to MCEMP1 for treatment or prevention of malignant tumors.
5 cl, 4 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MALIGNANT TUMOUR | 2016 |
|
RU2714205C2 |
IMMUNO-INDUCING AGENT | 2016 |
|
RU2744843C2 |
HERPES VACCINE | 2019 |
|
RU2731073C1 |
BIOSENSOR SYSTEM FOR FAST DETECTION OF DETERMINED COMPONENTS | 2016 |
|
RU2717658C2 |
HIV-1 SUBTYPE A P17 PROTEIN ANTIBODIES | 2019 |
|
RU2727673C1 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF MALIGNANT TUMOR | 2017 |
|
RU2766586C2 |
IMMUNE-INDUCING AGENT | 2017 |
|
RU2777992C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF MALIGNANT TUMOR | 2019 |
|
RU2781542C2 |
PEPTIDE DERIVED FROM FOXM1, AND INCLUDING ITS VACCINE | 2016 |
|
RU2738418C2 |
NUCLEIC ACID CONSTRUCTIONS AND VECTORS FOR GENOTHERAPY FOR TREATING WILSON'S DISEASE AND OTHER CONDITIONS | 2015 |
|
RU2745567C2 |
Authors
Dates
2021-09-22—Published
2017-03-27—Filed